OCTREOTIDE INJECTION Russian patent published in 2022 - IPC A61K9/08 A61K38/31 A61K47/10 

FIELD: medicine.

SUBSTANCE: present invention relates to a sterile solution for the treatment of diseases selected from acromegaly, carcinoid tumor, vasoactive intestinal peptide tumor, and combinations thereof, containing: octreotide in the form of pharmaceutically acceptable salt, present at a concentration equivalent from 2.0 to 2.5 mg/ml of a base of octreotide, mannitol at a concentration in the range from 20.0 to 25.0 mg/ml, and phenol, in a pharmaceutically acceptable carrier, such as water for injections, where the sterile solution is present in an injection device.

EFFECT: present invention provides for satisfactory bioavailability of octreotide in the form of salt.

10 cl, 5 tbl, 2 ex, 2 dwg